Fig. 1.
PD-1 Blocking Antibodies. In patients with severe pneumonia caused by COVID-19, monoclonal antibodies that block PD-1 activity will increase T cell proliferation, cytokine production and reduce death.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.